Residency · Iowa City, IA
Sponsored by University of Iowa Health Care Medical Center
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 90 citations · Alpa Sidhu
Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study.
Journal of medical genetics · 2024 · 42 citations · John Bernat
Gene therapy and gene correction: targets, progress, and challenges for treating human diseases.
Gene therapy · 2022 · 105 citations · Val Sheffield
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
Molecular genetics and metabolism · 2022 · 52 citations · John Bernat
A phase III, open-label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies.
Journal of inherited metabolic disease · 2025 · 15 citations · John Bernat
Consensus Recommendation for Mouse Models of Ocular Hypertension to Study Aqueous Humor Outflow and Its Mechanisms.
Investigative ophthalmology & visual science · 2022 · 47 citations ·
Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma.
Scientific reports · 2024 · 22 citations · Val Sheffield
Consensus guidelines for the monitoring and management of metachromatic leukodystrophy in the United States.
Cytotherapy · 2024 · 22 citations · John Bernat